Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion (Q44556166)

4 December 2017

Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion (English)

1 reference

4 December 2017

1 reference

Babu V Naidu

1

1 reference

4 December 2017

Steven M Woolley

2

1 reference

4 December 2017

Alexander S Farivar

3

1 reference

4 December 2017

Robert Thomas

4

1 reference

4 December 2017

Charles Fraga

5

1 reference

4 December 2017

Michael S Mulligan

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

The Journal of Thoracic and Cardiovascular Surgery

4 December 2017

1 reference

4 December 2017

126

1 reference

4 December 2017

2

1 reference

4 December 2017

482-489

1 reference

Regulation of the mevalonate pathway

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Nitric oxide synthase in models of focal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Molecular characterization of endothelin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Lung transplantation: a decade of experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Pattern of injury and the role of neutrophils in reperfusion injury of rat lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Direct vascular effects of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Bacterial toxins that target Rho proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on nitric oxide-induced hydroxyl radical generation in the rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

Mitochondrial reactive oxygen species trigger hypoxia-induced transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

The NF-kappa B and I kappa B proteins: new discoveries and insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900699-8

10.1016/S0022-5223(03)00699-8

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference